Cover Image

In silico study suggests potential drugs that target CD151 to treat breast cancer and glioblastoma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Gema Ramírez‐Salinas, Martha Cecilia Rosales‐Hernandéz, José Correa‐Basurto, Issac Guerrero‐González, Selene Saraí Hernández‐Castro, Marlet Martinez‐Archundia
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Computational Chemistry
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Homology Modeling and Blind Docking Approach Studies of Pig Heart Fumarase
by: José Trujillo Ferrara, Martha Cecilia Rosales Hernández y José Correa Basurto
Published: (2007)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
by: Mamoor, Shahan
Published: (2025)

RETRACTED: Identification of potential therapeutic targets for breast cancer using Mendelian randomization analysis and drug target prediction
by: Zhulan Huang, et al.
Published: (2024)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
by: Mamoor, Shahan
Published: (2026)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: PIK3CD.
by: Mamoor, Shahan
Published: (2025)

Impactos económicos potenciales del cambio climático en la ganadería: caso de México
by: Saúl Basurto Hernández
Published: (2023)

Impacto de la crisis en el sector agropecuario en México.
by: Saúl Basurto Hernández
Published: (2012)

TECHNICAL EFFICIENCY IN SMALL AND MEDIUM-SIZED FIRMS IN MEXICO: A STOCHASTIC FRONTIER ANALYSIS
by: Saúl Basurto Hernández
Published: (2022)

Antibody–drug conjugates in breast cancer
by: Elizabeth A. Sakach, et al.
Published: (2026)

Evaluation of suppressor behavior of guanidine‐derived metformin and galegine as novel potential drugs for cancer treatment: an in silico study
by: Mohammad Behrouzi Varjovi, et al.
Published: (2024)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
by: Mamoor, Shahan
Published: (2026)

Hacia una metodología crítica e incluyente: el caso de la entrevista etnográfica a personas sordas
by: Saraí Hernández Barrientos
Published: (2022)

Effect of chitosan-carvacrol edible coatings on the quality and shelf life of tilapia (Oreochromis niloticus) fillets stored in ice
by: Saraí Chaparro-Hernández
Published: (2015)

Ligand recognition properties of the vasopressin V2 receptor studied under QSAR and molecular modeling strategies
by: Martínez-Archundia, Marlet, et al.
Published: (2017)

Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy
by: Helen M. Johnson, et al.
Published: (2024)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
by: Mamoor, Shahan
Published: (2025)

Theoretical Study of Isoindolines to Identify them as Cyclooxygenase-1 and -2 Inhibitors by Docking Simulations
by: José Correa-Basurto
Published: (2007)

Centromedian nucleus targeting in the pediatric population treated with thalamic responsive neurostimulation for drug‐resistant epilepsy
by: Marian Michael Bercu, et al.
Published: (2025)

TRAIL ‐ PEG ‐Apt‐ PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model
by: Gulen Melike Demirbolat, et al.
Published: (2026)

Use of antidepressants and potential drug interactions in cancer patients treated at a hospital in the Southern Brazil
by: Kelly Helena Kuhn
Published: (2021)

Input files, parameters, and scripts used for the computational mapping and targeting of BK channel protein–protein interactions in breast cancer
by: Vergara-Jaque, Ariela, et al.
Published: (2026)

Homology Modeling and Blind Docking Approach Studies of Pig Heart Fumarase
by: Martha Cecilia Rosales
Published: (2007)

Synergistic cytotoxic activity on breast cancer cells by tetrahydroxyquinone and photothermal therapy
by: Ximena A. Flores‐Arevalo, et al.
Published: (2026)

Fast Most Similar Neighbor (MSN) classifiers for Mixed Data
by: Selene Hernández Rodríguez
Published: (2010)

Generative design and validation of therapeutic peptides for glioblastoma based on a potential target ATP5A
by: Qian, Hao, et al.
Published: (2025)